[Use of lactulose in the treatment of chronic renal failure].
The effectiveness and tolerance of lactulose were studied in 15 patients suffereing from terminal chronic renal insufficiency under conservative treatment with hypoproteic diet. The drug was administered in doses such that 2-4 soft faeces discharges were obtained daily and in most cases led to an increase in the feeling of wellbeing, a reduction in arterial pressure, a reduction in potassiaemia and frequently in azotaemia, with no change in residual renal function.
D000293:Adolescent; D000328:Adult; D004044:Dietary Proteins; D004187:Disaccharides / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000178:diet therapy / Q000188:drug therapy*; D007792:Lactulose / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D014508:Urea / Q000097:blood
D004044:Dietary Proteins; D004187:Disaccharides; D007792:Lactulose; D014508:Urea
L'impiego del lattulosio nella terapia dell'insufficienza renale cronica.